Transdermal absorption formulation of total alkaloid of common monkshood root and preparation process thereof
A transdermal absorption preparation and total alkaloid technology, applied in anti-inflammatory agents, drug combinations, pharmaceutical formulas, etc., can solve the problems of patients' psychological burden, inconvenient use of black plaster, and large skin irritation, so as to avoid first-pass Effects and adverse reactions such as gastrointestinal tract, reducing the number of administrations, and the effect of constant blood concentration
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0039] Example 1: Multilayer Reservoir Matrix Drug Delivery System
[0040] 1. This embodiment includes four parts: a reservoir layer, an adhesive layer, a backing layer and a protective layer, wherein the drug reservoir layer of the reservoir layer includes two layers: a drug reservoir layer 1 and a drug reservoir layer 2, and the weight of the drug reservoir layer 1 is The ratio is: 0.21 part of total alkaloid extract of Chuanwu, 2 parts of PVA+PVP (2:1) solution, 0.3 part of propylene glycol, 0.03 part of azone, and 0.46 part of others; the weight ratio of drug storage layer 2 is: 0.15 part of alkaloid extract, 1.50 part of pressure-sensitive adhesive, 0.30 part of propylene glycol, 0.03 part of azone, and 1.12 part of others; the adhesive layer includes 1 part of pressure-sensitive adhesive and 0.1 part of thickener. The other component in this example is water.
[0041] 3. The process is:
[0042] After heating and dissolving the drug in the drug storage layer 1 with wa...
Embodiment 2
[0044] Example 2: Polymer Matrix Drug Delivery System
[0045] 1. This embodiment includes four parts: a reservoir layer, an adhesive layer, a backing layer and a protective layer, wherein the drug reservoir layer of the reservoir layer includes: 0.30 part of the total alkaloid extract of Chuanwu, PVA+PVP (2:1 ) solution 2 parts, propylene glycol 0.40 parts, azone 0.04 parts, other 1.26 parts; the adhesive layer includes 2 parts of pressure sensitive adhesive and 0.5 part of thickener.
[0046] The other component in this example is water.
[0047] 2. The process is:
[0048]Mix the drug in the drug storage layer, the skeleton material solution and the penetration enhancer evenly, place it on a clean, flat and smooth glass plate to form a thin film, dry at 60-80 °C, release the film, and stick it on the release paper that has been removed. , mix the pressure-sensitive adhesive and thickener, lay a film on the release paper, dry it, and laminate the drug storage layer and the...
Embodiment 3
[0050] Example 3: Adhesive matrix drug delivery system
[0051] 1. This embodiment includes four parts: a reservoir layer, an adhesive layer, a backing layer and a protective layer, wherein the drug reservoir layer of the reservoir layer includes: 0.30 part of the total alkaloid extract of A. 0.40 part, azone 0.04 part, other 1.26 part. The other component in this example is water.
[0052] 2. The process is:
[0053] Mix the drug, pressure-sensitive adhesive, and penetration enhancer in the drug storage layer evenly, heat and defoaming, place it in a mold padded with release paper, lay the film, remove the mold, dry at 80 °C for 2 hours, and paste it on Reinforced sticker with release paper removed, and that's it.
[0054] Others are the same as in Example 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com